BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8611058)

  • 1. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence.
    O'Malley SS; Jaffe AJ; Chang G; Rode S; Schottenfeld R; Meyer RE; Rounsaville B
    Arch Gen Psychiatry; 1996 Mar; 53(3):217-24. PubMed ID: 8611058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone and coping skills therapy for alcohol dependence. A controlled study.
    O'Malley SS; Jaffe AJ; Chang G; Schottenfeld RS; Meyer RE; Rounsaville B
    Arch Gen Psychiatry; 1992 Nov; 49(11):881-7. PubMed ID: 1444726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone and alcohol dependence. Role of subject compliance.
    Volpicelli JR; Rhines KC; Rhines JS; Volpicelli LA; Alterman AI; O'Brien CP
    Arch Gen Psychiatry; 1997 Aug; 54(8):737-42. PubMed ID: 9283509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naltrexone on alcohol "high" in alcoholics.
    Volpicelli JR; Watson NT; King AC; Sherman CE; O'Brien CP
    Am J Psychiatry; 1995 Apr; 152(4):613-5. PubMed ID: 7694913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in the treatment of alcohol dependence.
    Volpicelli JR; Alterman AI; Hayashida M; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):876-80. PubMed ID: 1345133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.
    Heinälä P; Alho H; Kiianmaa K; Lönnqvist J; Kuoppasalmi K; Sinclair JD
    J Clin Psychopharmacol; 2001 Jun; 21(3):287-92. PubMed ID: 11386491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
    Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
    JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.
    Jaffe AJ; Rounsaville B; Chang G; Schottenfeld RS; Meyer RE; O'Malley SS
    J Consult Clin Psychol; 1996 Oct; 64(5):1044-53. PubMed ID: 8916634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment.
    Davidson D; Wirtz PW; Gulliver SB; Longabaugh R
    Psychopharmacology (Berl); 2007 Sep; 194(1):1-10. PubMed ID: 17514344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in coping behavior in a randomized controlled trial of concurrent treatment for PTSD and alcohol dependence.
    Zang Y; Yu J; Chazin D; Asnaani A; Zandberg LJ; Foa EB
    Behav Res Ther; 2017 Mar; 90():9-15. PubMed ID: 27930926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.
    Schmitz JM; Stotts AL; Sayre SL; DeLaune KA; Grabowski J
    Am J Addict; 2004; 13(4):333-41. PubMed ID: 15370932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of a "slip" among alcoholics treated with naltrexone or placebo.
    O'Malley SS; Jaffe AJ; Rode S; Rounsaville BJ
    Am J Psychiatry; 1996 Feb; 153(2):281-3. PubMed ID: 8561215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.